Literature DB >> 1630157

Longitudinal Gompertzian analysis of ALS mortality in England and Wales, 1963-1989: estimates of susceptibility in the general population.

S Neilson1, I Robinson, M Hunter.   

Abstract

Mortality statistics in amyotrophic lateral sclerosis (ALS), which is more commonly and generally termed motoneurone disease (MND) in the United Kingdom, have been shown to reflect the incidence of previously diagnosed cases of the disease in a more complete way than in other conditions [1,2]. An analysis of changing patterns of mortality may therefore be a particularly appropriate way of tracing the underlying trends in the disease and is in principle a useful way of investigating the relationship between environmental and genetically controlled factors in the genesis of the condition. The majority of analyses so far have concentrated on the crude rise in reported mortality rates evident in recent decades in a number of countries [2-5], on the uneven geographical distribution [6,7] and on the complex range of plausible causes for these reported rises. Debates have centred on whether the increases represent 'real' or 'artifactual' changes, with no apparent resolution of the issue [8,3]. Recently Riggs [9] proposed a novel way of analysing this issue by using a Gompertzian model and provided evidence of the existence of an inherently susceptible subset of the US population. Riggs indicated that while the rise in ALS mortality is real, it is for the most part the result of an increase in the size of this inherently susceptible sub-population due to greater longevity. In order to examine the wider applicability of a Gompertzian model to ALS the technique has been replicated with the mortality rates for England and Wales for the 27-year period from 1963 to 1989. The technique has been developed and extended to produce an estimate of the size of the inherently susceptible sub-population (both male and female) over the entire period.

Entities:  

Mesh:

Year:  1992        PMID: 1630157     DOI: 10.1016/0047-6374(92)90107-o

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  7 in total

Review 1.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

Authors:  G C Román
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

2.  Ecological correlates of motor neuron disease mortality: a hypothesis concerning an epidemiological association with radon gas and gamma exposure.

Authors:  S Neilson; I Robinson; F C Rose
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

3.  Prenatal diagnosis of late onset diseases.

Authors:  I Robinson; S Neilson
Journal:  BMJ       Date:  1993-04-17

4.  Motor neuron disease in a defined English population: estimates of incidence and mortality.

Authors:  G Dean; M Quigley; M Goldacre
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

5.  Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation.

Authors:  S Neilson; I Robinson; A Alperovitch
Journal:  J Neurol       Date:  1994-06       Impact factor: 4.849

Review 6.  Smoking may be considered an established risk factor for sporadic ALS.

Authors:  Carmel Armon
Journal:  Neurology       Date:  2009-11-17       Impact factor: 9.910

7.  Incidence, Prevalence and Geographical Clustering of Motor Neuron Disease in the Netherlands.

Authors:  Adriaan D de Jongh; Ruben P A van Eijk; Susan M Peters; Michael A van Es; Anja M C Horemans; Anneke J van der Kooi; Nicol C Voermans; Roel C H Vermeulen; Jan H Veldink; Leonard H van den Berg
Journal:  Neurology       Date:  2021-01-20       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.